A landmark new paper published in The Lancet announces the renaming of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS), reflecting a broader and more accurate understanding of the condition. Developed through an extensive global consensus process involving clinicians, researchers, and people living…
How should premature/primary ovarian insufficiency (POI) be diagnosed and managed, based on the best available evidence from published literature? POI presents a significant challenge to women’s health, with far-reaching implications, both physically and emotionally. The potential implications include adverse effects on quality of life, on…
The International Menopause Society (IMS) White Paper addresses the key controversies around menopause hormone therapy (MHT). About IMS The International Menopause Society (IMS) brings together the world’s leading experts to collaborate and share knowledge about all aspects of aging in women. The IMS advocates evidence-based…
Premature ovarian insufficiency (POI) affects at least 1 in 100 women and has long-term risks of osteoporosis and cardiovascular disease. Oestrogen replacement therapy is recommended up to the age of natural menopause but there is little evidence to guide women and health professionals on their…
Emotional processing in people with premenstrual difficulties & “healthy controls” – online study This study aims to explore whether individuals who have premenstrual difficulties process their emotions differently to those who don’t experience premenstrual difficulties. How we process our emotions involves how we think about…
Q & As from Dr Nick Panay, Founder and Director of Hormone Health Q1: Is it possible to confuse menopause symptoms with Coronavirus symptoms? A: Hot flushes, sweats, aches and pains and tiredness induced by the menopause could be similar to Coronavirus symptoms, but the…
This study confirmed a statistically significant relationship between age of menopause and the primary cardiovascular outcome measure.
We would like to reassure all of our patient’s that we are taking the necessary precautions to control the spread of COVID-19 by offering telephone consultations to all of our patients, unless a face to face consultation is necessary.
Agreement among leading experts about the benefits and risks of testosterone therapy for postmenopausal women.
An article posted by Good Housekeeping this week made reference to one of Nick Panay’s papers.